OpenAlex
PricingAboutJobs
Log inGet started
Work

Antitumor activity of rituximab plus thalidomide in patients with relapsed/refractory mantle cell lymphoma

HTML

Year: 2004
Type: article
Study design: Clinical Trial
Source: Blood
DOI: 10.1182/blood-2004-03-1091
Authors: Hannes Kaufmann, Markus Raderer, Stefan Wöhrer, Andreas Püspök, Alexander Bankier, Christoph Zielinski, Andreas Chott, Johannes Drach
Institutions: University of Vienna, Medical University of Vienna
Language: English

Topic: Lymphoma Diagnosis and Treatment
Subfield: Pathology and Forensic Medicine
Field: Medicine
Domain: Health Sciences
Keywords: rituximab, thalidomide, mantle cell lymphoma, relapsed/refractory lymphoma, combination therapy, tumor microenvironment, progression-free survival, complete response, thromboembolic events, neutropenia, maintenance therapy
SDG: Good health and well-being

Open Access status: closed

Funder: National Cancer Institute
OpenAlex ID: W2027362911
FWCI: 11.12
Cites: 25
Cited by: 172
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms